▶ 調査レポート

血圧障害薬の世界市場予測 2024年:企業別、地域別、種類・用途別(~2024)

• 英文タイトル:Global Blood Pressure Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。血圧障害薬の世界市場予測 2024年:企業別、地域別、種類・用途別(~2024) / Global Blood Pressure Disorders Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / B-GIR08C0858資料のイメージです。• レポートコード:B-GIR08C0858
• 出版社/出版日:GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、136ページ
• 納品方法:Eメール
• 産業分類:Medical Care
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、血圧障害薬の世界市場について調べ、まとめました。種類別セグメントは、利尿薬、アンジオテンシン変換酵素(ACE)阻害薬、アンジオテンシン受容体拮抗薬(ARB)、その他等、用途別セグメントは、等に区分しました。血圧障害薬の世界市場概観、企業動向、企業別血圧障害薬シェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・血圧障害薬の市場概観
・血圧障害薬の企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・血圧障害薬の企業別販売動向、市場シェア、市場集中度、競争動向
・血圧障害薬の世界市場規模
・血圧障害薬の北米市場分析(アメリカ、カナダ、メキシコ等)
・血圧障害薬のアメリカ市場規模推移
・血圧障害薬のカナダ市場規模推移
・血圧障害薬のメキシコ市場規模推移
・血圧障害薬のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・血圧障害薬のドイツ市場規模推移
・血圧障害薬のイギリス市場規模推移
・血圧障害薬のロシア市場規模推移
・血圧障害薬のアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・血圧障害薬の日本市場規模推移
・血圧障害薬の中国市場規模推移
・血圧障害薬の韓国市場規模推移
・血圧障害薬のインド市場規模推移
・血圧障害薬の東南アジア市場規模推移
・血圧障害薬の南米市場分析(ブラジル、アルゼンチン等)
・血圧障害薬の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・血圧障害薬の種類別分析/販売量、売上、市場シェア(利尿薬、アンジオテンシン変換酵素(ACE)阻害薬、アンジオテンシン受容体拮抗薬(ARB)、その他)
・血圧障害薬の用途別分析/市場規模()
・血圧障害薬の市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・血圧障害薬の販売チャネル・代理店・貿易業者・ディーラー分析

Blood pressure disorder drug development technology and related units

Scope of the Report:
High blood pressure, also known as high blood pressure, is a condition in which arterial blood pressure continues to rise. Many factors affect blood pressure, including hormone levels in the body, water and salt levels, and kidney, nervous system and blood vessels.
Most hypertensive patients do not have any signs or symptoms even if their blood pressure readings reach dangerously high levels. Although a small number of people with early-onset hypertension may experience dizziness, dizziness, or more nosebleeds than normal, these symptoms and symptoms usually do not occur until the high blood pressure reaches a critical stage. There are currently 253 products under development.
The global Blood Pressure Disorders Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Blood Pressure Disorders Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Blood Pressure Disorders Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Blood Pressure Disorders Drug market by product type and applications/end industries.

Market Segment by Companies, this report covers
A1M Pharma AB
Acceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
Bial – Portela & Ca SA
Bioblue Technologies Inc
Biogen Inc
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics Inc
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co Ltd
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Diuretics
Angiotensin Converting Enzyme (ACE) Inhibitors
Angiotensin Receptor Blockers (ARBs)
Others

Market Segment by Applications, can be divided into
Hypertension
Hypotension
Pulmonary Hypertension

レポート目次

Table of Contents

1 Blood Pressure Disorders Drug Market Overview
1.1 Product Overview and Scope of Blood Pressure Disorders Drug
1.2 Classification of Blood Pressure Disorders Drug by Types
1.2.1 Global Blood Pressure Disorders Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Blood Pressure Disorders Drug Revenue Market Share by Types in 2018
1.2.3 Diuretics
1.2.4 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.5 Angiotensin Receptor Blockers (ARBs)
1.2.6 Others
1.3 Global Blood Pressure Disorders Drug Market by Application
1.3.1 Global Blood Pressure Disorders Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hypertension
1.3.3 Hypotension
1.3.4 Pulmonary Hypertension
1.4 Global Blood Pressure Disorders Drug Market by Regions
1.4.1 Global Blood Pressure Disorders Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Blood Pressure Disorders Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Blood Pressure Disorders Drug (2014-2024)
2 Company Profiles
2.1 A1M Pharma AB
2.1.1 Business Overview
2.1.2 Blood Pressure Disorders Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 A1M Pharma AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 Acceleron Pharma Inc
2.2.1 Business Overview
2.2.2 Blood Pressure Disorders Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 Ache Laboratorios Farmaceuticos SA
2.3.1 Business Overview
2.3.2 Blood Pressure Disorders Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 Actelion Pharmaceuticals Ltd
2.4.1 Business Overview
2.4.2 Blood Pressure Disorders Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 Aerogen Ltd
2.5.1 Business Overview
2.5.2 Blood Pressure Disorders Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Aerogen Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 Anavex Life Sciences Corp
2.6.1 Business Overview
2.6.2 Blood Pressure Disorders Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 AnGes Inc
2.7.1 Business Overview
2.7.2 Blood Pressure Disorders Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AnGes Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.8 Arena Pharmaceuticals Inc
2.8.1 Business Overview
2.8.2 Blood Pressure Disorders Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.9 Ascendia Pharmaceuticals LLC
2.9.1 Business Overview
2.9.2 Blood Pressure Disorders Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.10 Ascendis Pharma A/S
2.10.1 Business Overview
2.10.2 Blood Pressure Disorders Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.11 AVEO Pharmaceuticals Inc
2.11.1 Business Overview
2.11.2 Blood Pressure Disorders Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.12 Bayer AG
2.12.1 Business Overview
2.12.2 Blood Pressure Disorders Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Bayer AG Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.13 Bial – Portela & Ca SA
2.13.1 Business Overview
2.13.2 Blood Pressure Disorders Drug Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bial – Portela & Ca SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.14 Bioblue Technologies Inc
2.14.1 Business Overview
2.14.2 Blood Pressure Disorders Drug Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.15 Biogen Inc
2.15.1 Business Overview
2.15.2 Blood Pressure Disorders Drug Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Biogen Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.16 Biolab Farmaceutica Ltda
2.16.1 Business Overview
2.16.2 Blood Pressure Disorders Drug Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.17 BioRestorative Therapies Inc
2.17.1 Business Overview
2.17.2 Blood Pressure Disorders Drug Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.18 Boryung Pharmaceutical Co Ltd
2.18.1 Business Overview
2.18.2 Blood Pressure Disorders Drug Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.19 Bristol-Myers Squibb Co
2.19.1 Business Overview
2.19.2 Blood Pressure Disorders Drug Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.20 Camurus AB
2.20.1 Business Overview
2.20.2 Blood Pressure Disorders Drug Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Camurus AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.21 Capricor Therapeutics Inc
2.21.1 Business Overview
2.21.2 Blood Pressure Disorders Drug Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.22 Celsion Corp
2.22.1 Business Overview
2.22.2 Blood Pressure Disorders Drug Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Celsion Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.23 Celtaxsys Inc
2.23.1 Business Overview
2.23.2 Blood Pressure Disorders Drug Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.24 Chiesi Farmaceutici SpA
2.24.1 Business Overview
2.24.2 Blood Pressure Disorders Drug Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.25 Chong Kun Dang Pharmaceutical Corp
2.25.1 Business Overview
2.25.2 Blood Pressure Disorders Drug Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.26 Chugai Pharmaceutical Co Ltd
2.26.1 Business Overview
2.26.2 Blood Pressure Disorders Drug Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.27 CJ HealthCare Corp
2.27.1 Business Overview
2.27.2 Blood Pressure Disorders Drug Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.28 Complexa Inc
2.28.1 Business Overview
2.28.2 Blood Pressure Disorders Drug Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Complexa Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
2.29 Corion Biotech Srl
2.29.1 Business Overview
2.29.2 Blood Pressure Disorders Drug Type and Applications
2.29.2.1 Product A
2.29.2.2 Product B
2.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Blood Pressure Disorders Drug Market Competition, by Players
3.1 Global Blood Pressure Disorders Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Blood Pressure Disorders Drug Players Market Share
3.2.2 Top 10 Blood Pressure Disorders Drug Players Market Share
3.3 Market Competition Trend
4 Global Blood Pressure Disorders Drug Market Size by Regions
4.1 Global Blood Pressure Disorders Drug Revenue and Market Share by Regions
4.2 North America Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
4.5 South America Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
5 North America Blood Pressure Disorders Drug Revenue by Countries
5.1 North America Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
5.2 USA Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
6 Europe Blood Pressure Disorders Drug Revenue by Countries
6.1 Europe Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
6.2 Germany Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
6.3 UK Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
6.4 France Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Blood Pressure Disorders Drug Revenue by Countries
7.1 Asia-Pacific Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
7.2 China Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
7.5 India Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
8 South America Blood Pressure Disorders Drug Revenue by Countries
8.1 South America Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
8.2 Brazil Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Blood Pressure Disorders Drug by Countries
9.1 Middle East and Africa Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
10 Global Blood Pressure Disorders Drug Market Segment by Type
10.1 Global Blood Pressure Disorders Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Blood Pressure Disorders Drug Market Forecast by Type (2019-2024)
10.3 Diuretics Revenue Growth Rate (2014-2024)
10.4 Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2014-2024)
10.5 Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Blood Pressure Disorders Drug Market Segment by Application
11.1 Global Blood Pressure Disorders Drug Revenue Market Share by Application (2014-2019)
11.2 Blood Pressure Disorders Drug Market Forecast by Application (2019-2024)
11.3 Hypertension Revenue Growth (2014-2019)
11.4 Hypotension Revenue Growth (2014-2019)
11.5 Pulmonary Hypertension Revenue Growth (2014-2019)
12 Global Blood Pressure Disorders Drug Market Size Forecast (2019-2024)
12.1 Global Blood Pressure Disorders Drug Market Size Forecast (2019-2024)
12.2 Global Blood Pressure Disorders Drug Market Forecast by Regions (2019-2024)
12.3 North America Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
12.4 Europe Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
12.6 South America Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Blood Pressure Disorders Drug Picture
Table Product Specifications of Blood Pressure Disorders Drug
Table Global Blood Pressure Disorders Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Blood Pressure Disorders Drug Revenue Market Share by Types in 2018
Figure Diuretics Picture
Figure Angiotensin Converting Enzyme (ACE) Inhibitors Picture
Figure Angiotensin Receptor Blockers (ARBs) Picture
Figure Others Picture
Table Global Blood Pressure Disorders Drug Revenue (Million USD) by Application (2014-2024)
Figure Blood Pressure Disorders Drug Revenue Market Share by Applications in 2018
Figure Hypertension Picture
Figure Hypotension Picture
Figure Pulmonary Hypertension Picture
Table Global Market Blood Pressure Disorders Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Blood Pressure Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Blood Pressure Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Blood Pressure Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Blood Pressure Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Blood Pressure Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Blood Pressure Disorders Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table A1M Pharma AB Basic Information, Manufacturing Base and Competitors
Table A1M Pharma AB Blood Pressure Disorders Drug Type and Applications
Table A1M Pharma AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Acceleron Pharma Inc Basic Information, Manufacturing Base and Competitors
Table Acceleron Pharma Inc Blood Pressure Disorders Drug Type and Applications
Table Acceleron Pharma Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Ache Laboratorios Farmaceuticos SA Basic Information, Manufacturing Base and Competitors
Table Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Type and Applications
Table Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Actelion Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Type and Applications
Table Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Aerogen Ltd Basic Information, Manufacturing Base and Competitors
Table Aerogen Ltd Blood Pressure Disorders Drug Type and Applications
Table Aerogen Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Anavex Life Sciences Corp Basic Information, Manufacturing Base and Competitors
Table Anavex Life Sciences Corp Blood Pressure Disorders Drug Type and Applications
Table Anavex Life Sciences Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AnGes Inc Basic Information, Manufacturing Base and Competitors
Table AnGes Inc Blood Pressure Disorders Drug Type and Applications
Table AnGes Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Arena Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Type and Applications
Table Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Ascendia Pharmaceuticals LLC Basic Information, Manufacturing Base and Competitors
Table Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Type and Applications
Table Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Ascendis Pharma A/S Basic Information, Manufacturing Base and Competitors
Table Ascendis Pharma A/S Blood Pressure Disorders Drug Type and Applications
Table Ascendis Pharma A/S Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table AVEO Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Type and Applications
Table AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer AG Basic Information, Manufacturing Base and Competitors
Table Bayer AG Blood Pressure Disorders Drug Type and Applications
Table Bayer AG Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Bial - Portela & Ca SA Basic Information, Manufacturing Base and Competitors
Table Bial - Portela & Ca SA Blood Pressure Disorders Drug Type and Applications
Table Bial - Portela & Ca SA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Bioblue Technologies Inc Basic Information, Manufacturing Base and Competitors
Table Bioblue Technologies Inc Blood Pressure Disorders Drug Type and Applications
Table Bioblue Technologies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Inc Basic Information, Manufacturing Base and Competitors
Table Biogen Inc Blood Pressure Disorders Drug Type and Applications
Table Biogen Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Biolab Farmaceutica Ltda Basic Information, Manufacturing Base and Competitors
Table Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Type and Applications
Table Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table BioRestorative Therapies Inc Basic Information, Manufacturing Base and Competitors
Table BioRestorative Therapies Inc Blood Pressure Disorders Drug Type and Applications
Table BioRestorative Therapies Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Boryung Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Type and Applications
Table Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Co Blood Pressure Disorders Drug Type and Applications
Table Bristol-Myers Squibb Co Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Camurus AB Basic Information, Manufacturing Base and Competitors
Table Camurus AB Blood Pressure Disorders Drug Type and Applications
Table Camurus AB Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Capricor Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table Capricor Therapeutics Inc Blood Pressure Disorders Drug Type and Applications
Table Capricor Therapeutics Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Celsion Corp Basic Information, Manufacturing Base and Competitors
Table Celsion Corp Blood Pressure Disorders Drug Type and Applications
Table Celsion Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Celtaxsys Inc Basic Information, Manufacturing Base and Competitors
Table Celtaxsys Inc Blood Pressure Disorders Drug Type and Applications
Table Celtaxsys Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Chiesi Farmaceutici SpA Basic Information, Manufacturing Base and Competitors
Table Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Type and Applications
Table Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Chong Kun Dang Pharmaceutical Corp Basic Information, Manufacturing Base and Competitors
Table Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Type and Applications
Table Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Chugai Pharmaceutical Co Ltd Basic Information, Manufacturing Base and Competitors
Table Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Type and Applications
Table Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table CJ HealthCare Corp Basic Information, Manufacturing Base and Competitors
Table CJ HealthCare Corp Blood Pressure Disorders Drug Type and Applications
Table CJ HealthCare Corp Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Complexa Inc Basic Information, Manufacturing Base and Competitors
Table Complexa Inc Blood Pressure Disorders Drug Type and Applications
Table Complexa Inc Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Corion Biotech Srl Basic Information, Manufacturing Base and Competitors
Table Corion Biotech Srl Blood Pressure Disorders Drug Type and Applications
Table Corion Biotech Srl Blood Pressure Disorders Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Blood Pressure Disorders Drug Revenue (Million USD) by Players (2014-2019)
Table Global Blood Pressure Disorders Drug Revenue Share by Players (2014-2019)
Figure Global Blood Pressure Disorders Drug Revenue Share by Players in 2017
Figure Global Blood Pressure Disorders Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Blood Pressure Disorders Drug Revenue Market Share in 2018
Figure Global Top 10 Players Blood Pressure Disorders Drug Revenue Market Share in 2018
Figure Global Blood Pressure Disorders Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Blood Pressure Disorders Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Blood Pressure Disorders Drug Revenue Market Share by Regions (2014-2019)
Figure Global Blood Pressure Disorders Drug Revenue Market Share by Regions (2014-2019)
Figure Global Blood Pressure Disorders Drug Revenue Market Share by Regions in 2018
Figure North America Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Europe Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure South America Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Table North America Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
Table North America Blood Pressure Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure North America Blood Pressure Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure North America Blood Pressure Disorders Drug Revenue Market Share by Countries in 2018
Figure USA Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Canada Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Table Europe Blood Pressure Disorders Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Blood Pressure Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Blood Pressure Disorders Drug Revenue Market Share by Countries in 2018
Figure Germany Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure UK Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure France Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Russia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Italy Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Blood Pressure Disorders Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Blood Pressure Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Blood Pressure Disorders Drug Revenue Market Share by Countries in 2018
Figure China Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Japan Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Korea Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure India Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Table South America Blood Pressure Disorders Drug Revenue by Countries (2014-2019)
Table South America Blood Pressure Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure South America Blood Pressure Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure South America Blood Pressure Disorders Drug Revenue Market Share by Countries in 2018
Figure Brazil Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Blood Pressure Disorders Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Blood Pressure Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Blood Pressure Disorders Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Blood Pressure Disorders Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure UAE Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Blood Pressure Disorders Drug Revenue and Growth Rate (2014-2019)
Table Global Blood Pressure Disorders Drug Revenue (Million USD) by Type (2014-2019)
Table Global Blood Pressure Disorders Drug Revenue Share by Type (2014-2019)
Figure Global Blood Pressure Disorders Drug Revenue Share by Type (2014-2019)
Figure Global Blood Pressure Disorders Drug Revenue Share by Type in 2018
Table Global Blood Pressure Disorders Drug Revenue Forecast by Type (2019-2024)
Figure Global Blood Pressure Disorders Drug Market Share Forecast by Type (2019-2024)
Figure Global Diuretics Revenue Growth Rate (2014-2019)
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Angiotensin Receptor Blockers (ARBs) Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Blood Pressure Disorders Drug Revenue by Application (2014-2019)
Table Global Blood Pressure Disorders Drug Revenue Share by Application (2014-2019)
Figure Global Blood Pressure Disorders Drug Revenue Share by Application (2014-2019)
Figure Global Blood Pressure Disorders Drug Revenue Share by Application in 2018
Table Global Blood Pressure Disorders Drug Revenue Forecast by Application (2019-2024)
Figure Global Blood Pressure Disorders Drug Market Share Forecast by Application (2019-2024)
Figure Global Hypertension Revenue Growth Rate (2014-2019)
Figure Global Hypotension Revenue Growth Rate (2014-2019)
Figure Global Pulmonary Hypertension Revenue Growth Rate (2014-2019)
Figure Global Blood Pressure Disorders Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Blood Pressure Disorders Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Blood Pressure Disorders Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
Figure Europe Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
Figure South America Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Blood Pressure Disorders Drug Revenue Market Forecast (2019-2024)